O. H. Y. Yu

First name
O.
Last name
H. Y. Yu
Larose, S., Filliter, C., Platt, R. W., H. Y. Yu, O., & Filion, K. B. (2023). Long-acting insulin analogues and the risk of diabetic retinopathy among patients with type 2 diabetes: A population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.15106
View
Aloe, S., Filliter, C., Salmasi, S., Igweokpala, S., H. Y. Yu, O., Tagalakis, V., & Filion, K. B. (2023). SGLT2 Inhibitors and the Risk of Venous Thromboembolism: A Population-based Cohort Study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.15787
View
Yu, Y. H., Platt, R. W., Reynier, P., H. Y. Yu, O., & Filion, K. B. (2023). Use of metformin and insulin among pregnant women with gestation diabetes in the United Kingdom: A population-based cohort study. Diabet Med, e15108. http://doi.org/10.1111/dme.15108
View
Islam, N., Reynier, P., Douros, A., H. Y. Yu, O., & Filion, K. B. (2023). Sulfonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: a population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.15000
View
Pradhan, R., Lu, S., Yin, H., H. Y. Yu, O., Ernst, P., Suissa, S., & Azoulay, L. (2022). Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study. Bmj, 379, e071380. http://doi.org/10.1136/bmj-2022-071380
View
Brunetti, V. C., St-Jean, A., Dell'Aniello, S., Fisher, A., H. Y. Yu, O., Bugden, S. C., et al. (2022). Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom. Bmc Endocr Disord, 22, 241. http://doi.org/10.1186/s12902-022-01140-1
View
Abrahami, D., Tesfaye, H., Yin, H., Vine, S., Hicks, B., H. Y. Yu, O., et al. (2022). Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study. Diabetes Care. http://doi.org/10.2337/dc22-1174
View
Cao, T. X. D., Filliter, C., Montastruc, F., H. Y. Yu, O., Fergusson, E., Rej, S., et al. (2022). Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths. J Affect Disord, 318, 231-237. http://doi.org/10.1016/j.jad.2022.08.094
View
Pradhan, R., Yin, H., H. Y. Yu, O., & Azoulay, L. (2022). Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc22-0712
View
Brunetti, V. C., H. Y. Yu, O., Platt, R. W., & Filion, K. B. (2022). The Association of Long-Acting Insulin Analogue Use Versus Neutral Protamine Hagedorn Insulin Use With Major Adverse Cardiovascular Events Among Individuals With Type 2 Diabetes: A Population-Based Cohort Study. Diabetes Obes Metab. http://doi.org/10.1111/dom.14802
View